Abstract |
Aplog-1 is a unique analog of tumor-promoting aplysiatoxin that inhibits tumor-promotion by phorbol diesters and proliferation of tumor cells. While the structural features relevant to the biological activities of Aplog-1 remain to be identified, recent studies by us have suggested that local hydrophobicity around the spiroketal moiety of Aplog-1 is a crucial determinant of its anti-proliferative activity. This hypothesis led us to design 12,12-dimethyl-Aplog-1 (3), in which a hydrophobic geminal dimethyl group is installed proximal to the spiroketal moiety to improve biological potency. As expected, 3 was more effective than Aplog-1 in inhibiting cancer cell growth and binding to protein kinase Cδ, a putative receptor responsible for the biological response of Aplog-1. Moreover, an induction test on Epstein-Barr virus early antigen demonstrated 3 to be a better anti- tumor promoter than Aplog-1. These results indicate that 3 is a superior derivative of Aplog-1, and thus a more promising lead for anti- cancer drugs.
|
Authors | Yu Nakagawa, Masayuki Kikumori, Ryo C Yanagita, Akira Murakami, Harukuni Tokuda, Hiroshi Nagai, Kazuhiro Irie |
Journal | Bioscience, biotechnology, and biochemistry
(Biosci Biotechnol Biochem)
Vol. 75
Issue 6
Pg. 1167-73
( 2011)
ISSN: 1347-6947 [Electronic] England |
PMID | 21670518
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anticarcinogenic Agents
- Antigens, Viral
- Carcinogens
- Epstein-Barr virus early antigen
- Furans
- Lyngbya Toxins
- Phorbol Esters
- Spiro Compounds
- spiroketal
- aplysiatoxin
- Protein Kinase C-delta
|
Topics |
- Anticarcinogenic Agents
(chemical synthesis, pharmacology)
- Antigens, Viral
(analysis, biosynthesis)
- B-Lymphocytes
(pathology, virology)
- Carcinogens
(antagonists & inhibitors, pharmacology)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Dose-Response Relationship, Drug
- Epstein-Barr Virus Infections
(drug therapy, pathology, prevention & control)
- Furans
(chemical synthesis, pharmacology)
- Herpesvirus 4, Human
(drug effects, physiology)
- Humans
- Hydrophobic and Hydrophilic Interactions
- Lyngbya Toxins
(adverse effects, pharmacology)
- Methylation
- Neoplasms
(drug therapy, pathology, prevention & control)
- Phorbol Esters
(adverse effects, pharmacology)
- Protein Binding
- Protein Kinase C-delta
(antagonists & inhibitors, metabolism)
- Spiro Compounds
(chemical synthesis, pharmacology)
- Structure-Activity Relationship
|